Pages that link to "Q37593661"
Jump to navigation
Jump to search
The following pages link to Taxol: a novel investigational antimicrotubule agent (Q37593661):
Displaying 50 items.
- Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer (Q24657308) (← links)
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II study (Q24812405) (← links)
- Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yes (Q26766180) (← links)
- Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation Therapy (Q26775004) (← links)
- Breakthrough therapy for peritoneal carcinomatosis of gastric cancer: Intraperitoneal chemotherapy with taxanes (Q26776201) (← links)
- Enabling anticancer therapeutics by nanoparticle carriers: the delivery of Paclitaxel (Q26999288) (← links)
- Structural and Biochemical Studies of a Fluoroacetyl-CoA-Specific Thioesterase Reveal a Molecular Basis for Fluorine Selectivity (Q27664447) (← links)
- Iron oxide nanoparticles for magnetically-guided and magnetically-responsive drug delivery (Q28085546) (← links)
- Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis (Q28186614) (← links)
- Total synthesis of taxol (Q28237249) (← links)
- Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced oesophageal cancer (Q28343367) (← links)
- The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer (Q28540889) (← links)
- Protein quantitative trait loci identify novel candidates modulating cellular response to chemotherapy (Q28541831) (← links)
- In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug (Q28754742) (← links)
- Trimethyl lock: a trigger for molecular release in chemistry, biology, and pharmacology (Q29303893) (← links)
- Interaction of taxol with human serum albumin. (Q30326403) (← links)
- Clinical Translation of Nanomedicine. (Q30355939) (← links)
- Mitotic slippage in non-cancer cells induced by a microtubule disruptor, disorazole C1. (Q30493535) (← links)
- Microtubule Stabilization Reduces Scarring and Causes Axon Regeneration After Spinal Cord Injury (Q30513561) (← links)
- Screening for pharmaceutically important taxoids in Taxus baccata var. Aurea corr. with CC/SPE/HPLC-PDA procedure (Q30633090) (← links)
- PLK1 blockade enhances therapeutic effects of radiation by inducing cell cycle arrest at the mitotic phase (Q30670722) (← links)
- A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma (Q30704009) (← links)
- Investigation of genotoxic effect of taxol plus radiation on mice bone marrow cells. (Q30783721) (← links)
- Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers (Q30983299) (← links)
- Germ cell tumors: an update of recent data and review of active protocols in stage I and metastatic disease (Q30994365) (← links)
- Polymeric micellar paclitaxel phosphorylates Bcl-2 and induces apoptotic regression of androgen-independent LNCaP prostate tumors. (Q31402222) (← links)
- Colchicine and griseofulvin inhibit VCAM-1 expression on human vascular endothelial cells - evidence for the association of VCAM-1 expression with microtubules (Q31823206) (← links)
- Expression of thymidine phosphorylase in peripheral blood cells of breast cancer patients is not increased by paclitaxel (Q33291247) (← links)
- Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment (Q33306061) (← links)
- Phase II study of paclitaxel (Genaxol) and cisplatin combination in treating Chinese patients with advanced non-small cell lung cancer (NSCLC). (Q33344579) (← links)
- First-line chemotherapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients (Q33348437) (← links)
- Paclitaxel and mitoxantrone in metastatic breast cancer: a phase II trial of the Italian Oncology Group for Cancer Research (Q33363308) (← links)
- Paclitaxel metabolites in human plasma and urine: Identification of 6α‐hydroxytaxol, 7‐epitaxol and taxol hydrolysis products using liquid chromatography/atmospheric‐pressure chemical ionization mass spectrometry (Q33483953) (← links)
- Phase I Trial of Taxol as a Radiation Sensitizer with Cisplatin in Advanced Cervical Cancer (Q33500803) (← links)
- Near-infrared light triggers release of Paclitaxel from biodegradable microspheres: photothermal effect and enhanced antitumor activity (Q33556049) (← links)
- The role of Bcl-xL and nuclear factor-kappaB in the effect of taxol on the viability of dendritic cells (Q33569063) (← links)
- Localized paclitaxel delivery (Q33653428) (← links)
- Serologic tumor markers, clinical biology, and therapy of prostatic carcinoma (Q33653596) (← links)
- Role of taxanes in adjuvant therapy (Q33853699) (← links)
- A soybean cDNA encoding a chromatin-binding peptide inhibits mitosis of mammalian cells (Q33862461) (← links)
- Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention (Q33903066) (← links)
- Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel (Q34005908) (← links)
- Novel combination chemotherapy in the treatment of non-small cell lung cancer (Q34181910) (← links)
- Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat (Q34211840) (← links)
- Taxol arrests the development of blood-stage Plasmodium falciparum in vitro and Plasmodium chabaudi adami in malaria-infected mice (Q34236200) (← links)
- Use of paclitaxel in patients with pre-existing cardiomyopathy: a review of our experience (Q34273153) (← links)
- Preclinical profile of cabazitaxel (Q34394251) (← links)
- Combination of taxanes, cisplatin and fluorouracil as induction chemotherapy for locally advanced head and neck cancer: a meta-analysis (Q34511068) (← links)
- The ADNP derived peptide, NAP modulates the tubulin pool: implication for neurotrophic and neuroprotective activities (Q34525286) (← links)
- Stent-based antirestenotic coatings (sirolimus/paclitaxel). (Q34547687) (← links)